This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels

Vincent Rezzouk-Hammachi
Partner at Bird & Bird
Speaker

Profile

I am a partner in our London office, looking after the Bird & Bird Privacy Solutions service line, within the Privacy & Data Protection team. I supervise Privacy & Data Protection compliance and consultancy engagements, which include Data Protection Officer and GDPR Representative services, across industries.

I am qualified to practise law in France (Paris Bar), and have over 12 years of experience in providing advisory assistance to clients data protection regulations, covering issues such as the General Data Protection Regulation, the U.K. GDPR and the ePrivacy directive.

I have a privacy background in both legal and consultancy and I am well-known to my clients for my positive and business-oriented approach to data protection compliance, across industries (Tech & Comms, Life Sciences, Media & Entertainments, Financial Services mainly).

In the past, I have been involved in several projects before the European Commission and the French Competition Authority, acting as a Monitoring Trustee team member in the context of large M&A operations.

I assist organisations across the world in implementing the General Data Protection Regulations (GDPR) and/or the UK-GDPR, helping them to transform legal requirements into business processes, or helping them to select tools to support these initiatives.

Acting as the lead Data Protection Officer for global organisations across industries, I am often involved in all interactions with data protection supervisory authorities.

Agenda Sessions

  • TRI DIALOGUE Utilising and Managing the Risk of Generative Artificial Intelligence in Day-to-Day Pharma Activities

    11:50